NewAmsterdam Pharma Company N.V. (NAMS)
(Delayed Data from NSDQ)
$16.39 USD
-0.61 (-3.59%)
Updated Aug 15, 2024 04:00 PM ET
After-Market: $16.33 -0.06 (-0.37%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 37% (93 out of 251)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.13 | 1.58 | 9.99 |
Current Quarter Estimate | -0.48 | -1.03 | 61.00 |
Year Ago Quarter Estimate | NA | -0.07 | 54.84 |
Next Quarter Estimate | -0.44 | -1.82 | 63.00 |
Next Year Estimate | -1.60 | 12.72 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -12.56 | 17.80 | 15.67 |
Next Year | 33.88 | 16.60 | 11.34 |
Last 5 Years | NA | 7.00 | 8.10 |
Next 5 Years | NA | 22.40 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -9.82 |
Price/Book (MRQ) | 3.95 | 1.47 |
Price/Cash Flow (MRFY) | NA | 8.80 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | -35.91% |
Return on Equity (TTM) | NA | -39.73% |
Debt to Equity (MRQ) | 0.00 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.